BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 700081)

  • 1. [Effect of amidine and guanidine derivatives on thrombocyte aggregation].
    Lakin KM; Lebid' IN; Gatash SV; Krylov IuF
    Farmakol Toksikol; 1978; 41(5):575-9. PubMed ID: 700081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of aggregation inhibitors on thrombocyte enzymatic activity].
    Lakin KM; Krylov IuF; Nepsha VD
    Farmakol Toksikol; 1978; 41(3):284-8. PubMed ID: 658372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationships between structure and the noradrenaline depleting effects of guanidine and amidine derivatives (author's transl)].
    Benkert B; Benthe HF; Göthert M; Schmoldt A
    Arzneimittelforschung; 1975 Sep; 25(9):1404-8. PubMed ID: 1242662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycyclic N-heterocyclic compounds. Part 62: Reaction of N-(quinazolin-4-yl)amidine derivatives with hydroxylamine hydrochloride and anti-platelet aggregation activity of the products.
    Okuda K; Zhang YX; Ohtomo H; Hirota T; Sasaki K
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):369-74. PubMed ID: 20190443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors of thrombocyte aggregation].
    Lakin KM; Makarov VA; Novikova NV; Tret'iak VM
    Farmakol Toksikol; 1983; 46(3):113-26. PubMed ID: 6134634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of etmozin on thrombocyte aggregation capacity].
    Dariskiĭ NV; Turilova AI; Korbut R; Marchenkevich E
    Biull Eksp Biol Med; 1982 May; 93(5):74-6. PubMed ID: 6807371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines.
    Calas M; Ouattara M; Piquet G; Ziora Z; Bordat Y; Ancelin ML; Escale R; Vial H
    J Med Chem; 2007 Dec; 50(25):6307-15. PubMed ID: 18004799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices].
    Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of benzamidine derivatives on platelet function.
    Glusa E; Markwardt F; Hoffmann A
    Acta Univ Carol Med Monogr; 1972; 53():215-9. PubMed ID: 4670730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].
    Mironiuk EP; Manevich EM; Piotrovskiĭ LB; Dumpis MA
    Farmakol Toksikol; 1987; 50(2):42-6. PubMed ID: 3582633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
    Kertscher HP; Ostermann G
    Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation inhibitors. II - N-heterocyclic aldoxime methiodides (1).
    Antonini I; Franchetti P; Grifantini M; Gulini U; Martelli S; Petrelli F
    Farmaco Sci; 1976 Nov; 31(11):809-16. PubMed ID: 1010032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of biologically active N-methyl derivatives of amidines and cyclized five-membered products of amidines with oxalyl chloride.
    Sondhi SM; Dinodia M; Jain S; Kumar A
    Eur J Med Chem; 2008 Dec; 43(12):2824-30. PubMed ID: 18022734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Derivatives of imidazo[1,2-c]quinazoline with inhibiting effect on platelet aggregation].
    Cardellini M; Franchetti P; Grifantini M; Martelli S; Petrelli F
    Farmaco Sci; 1975 Jul; 30(7):536-46. PubMed ID: 1149881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of trapidil and papaverine on thrombocyte aggregation and phosphodiesterase activity].
    Glusa E
    Farmakol Toksikol; 1986; 49(6):48-9. PubMed ID: 3028860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ADP-induced aggregation of human platelets in diabetes mellitus].
    Chirkov IuIu; Tyshchiuk IA; Severina IS; Starosel'tseva LK
    Vopr Med Khim; 1990; 36(4):20-2. PubMed ID: 2238525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.